| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
101,220 |
76,517 |
$7.12M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16,187 |
13,780 |
$4.81M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,928 |
17,403 |
$1.96M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
27,932 |
24,842 |
$1.93M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
24,346 |
21,922 |
$1.52M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
7,440 |
6,965 |
$1.15M |
| 70450 |
Computed tomography, head or brain; without contrast material |
5,346 |
4,990 |
$684K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,501 |
6,097 |
$672K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,868 |
5,382 |
$664K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
8,694 |
7,750 |
$620K |
| 59025 |
Fetal non-stress test |
3,861 |
2,698 |
$582K |
| G0378 |
Hospital observation service, per hour |
5,068 |
4,575 |
$556K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
6,287 |
3,704 |
$553K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,730 |
2,670 |
$499K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
21,667 |
9,532 |
$466K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,993 |
2,853 |
$451K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,802 |
1,194 |
$431K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
3,138 |
1,616 |
$424K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
1,980 |
1,418 |
$363K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,439 |
4,057 |
$252K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,671 |
1,574 |
$242K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
10,136 |
5,670 |
$239K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12,611 |
11,340 |
$225K |
| 64615 |
|
824 |
799 |
$223K |
| 70496 |
|
1,366 |
1,291 |
$213K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
8,435 |
7,123 |
$210K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
12,663 |
5,570 |
$206K |
| 76642 |
|
2,324 |
2,281 |
$202K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
3,332 |
2,774 |
$181K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
890 |
849 |
$180K |
| 93325 |
|
1,257 |
1,224 |
$160K |
| 95806 |
|
672 |
637 |
$140K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,184 |
2,047 |
$139K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,879 |
1,795 |
$134K |
| 20610 |
|
973 |
884 |
$123K |
| 80047 |
|
28,744 |
25,294 |
$122K |
| 76830 |
Ultrasound, transvaginal |
1,777 |
1,683 |
$118K |
| 97161 |
|
3,169 |
3,054 |
$118K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
1,688 |
1,638 |
$107K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
3,355 |
2,515 |
$104K |
| 93971 |
|
1,360 |
1,298 |
$103K |
| 93017 |
|
1,528 |
1,479 |
$96K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,840 |
2,813 |
$93K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,939 |
1,830 |
$85K |
| 64483 |
|
217 |
214 |
$79K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
2,310 |
1,464 |
$78K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
1,592 |
1,221 |
$77K |
| 80053 |
Comprehensive metabolic panel |
17,994 |
16,280 |
$67K |
| 84484 |
|
15,391 |
13,075 |
$62K |
| 71046 |
Radiologic examination, chest; 2 views |
5,328 |
5,019 |
$52K |
| 77066 |
Tomosynthesis, mammo |
1,743 |
1,714 |
$49K |
| 97165 |
|
1,233 |
1,186 |
$49K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
935 |
759 |
$43K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,877 |
2,844 |
$43K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,383 |
631 |
$43K |
| 80076 |
|
18,373 |
16,508 |
$42K |
| 76818 |
|
797 |
436 |
$42K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
27,239 |
24,246 |
$42K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,983 |
8,585 |
$40K |
| 20611 |
|
209 |
183 |
$40K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
288 |
265 |
$39K |
| 93975 |
|
605 |
573 |
$37K |
| 12001 |
|
171 |
162 |
$36K |
| 97162 |
|
1,046 |
1,020 |
$35K |
| 93976 |
|
888 |
831 |
$35K |
| 77065 |
Tomosynthesis, mammo |
1,162 |
1,043 |
$34K |
| 70498 |
|
1,130 |
1,065 |
$32K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,554 |
925 |
$31K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,348 |
2,226 |
$27K |
| 83880 |
|
3,840 |
3,568 |
$26K |
| 93970 |
|
321 |
312 |
$26K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,374 |
1,319 |
$26K |
| 76801 |
|
876 |
782 |
$25K |
| 76942 |
|
356 |
337 |
$25K |
| 36415 |
Collection of venous blood by venipuncture |
32,773 |
27,532 |
$23K |
| 97535 |
Self-care/home management training, each 15 minutes |
966 |
660 |
$23K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,104 |
8,717 |
$23K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
52,231 |
43,469 |
$22K |
| 73630 |
|
2,861 |
2,595 |
$22K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
153 |
146 |
$21K |
| 73610 |
|
2,174 |
1,974 |
$20K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,032 |
1,873 |
$19K |
| 83605 |
|
3,983 |
3,497 |
$19K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
850 |
792 |
$18K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,967 |
1,864 |
$18K |
| 71250 |
|
471 |
451 |
$17K |
| 73030 |
|
2,199 |
2,013 |
$16K |
| 97803 |
|
459 |
328 |
$16K |
| 97116 |
|
1,196 |
650 |
$15K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,036 |
1,876 |
$15K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
2,913 |
2,744 |
$14K |
| 73110 |
|
1,405 |
1,273 |
$14K |
| 73140 |
|
1,068 |
932 |
$14K |
| 87040 |
|
1,476 |
1,258 |
$14K |
| 85379 |
|
2,885 |
2,763 |
$14K |
| 94060 |
|
926 |
896 |
$12K |
| 90715 |
|
747 |
702 |
$12K |
| 76820 |
|
348 |
144 |
$11K |
| 73130 |
|
1,300 |
1,164 |
$11K |
| 72100 |
|
1,249 |
1,203 |
$11K |
| 93226 |
|
597 |
575 |
$11K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,387 |
1,177 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
6,704 |
6,513 |
$11K |
| 73564 |
|
2,244 |
2,025 |
$11K |
| 82607 |
|
1,999 |
1,940 |
$11K |
| 99490 |
Ccm add 20min |
564 |
558 |
$11K |
| 80061 |
Lipid panel |
3,894 |
3,795 |
$10K |
| 76821 |
|
298 |
125 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
10,039 |
9,212 |
$9K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
100 |
94 |
$9K |
| 93351 |
|
109 |
108 |
$7K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,088 |
5,703 |
$7K |
| 84439 |
|
2,089 |
2,009 |
$7K |
| 94729 |
|
982 |
951 |
$7K |
| 76770 |
|
89 |
88 |
$7K |
| J3490 |
Unclassified drugs |
1,771 |
1,448 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
20,718 |
17,836 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,072 |
1,047 |
$6K |
| 93296 |
|
792 |
776 |
$6K |
| 73502 |
|
769 |
731 |
$6K |
| 94726 |
|
705 |
680 |
$6K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
13 |
13 |
$6K |
| 93308 |
|
24 |
24 |
$5K |
| 85027 |
|
2,733 |
2,499 |
$5K |
| Q3014 |
Telehealth originating site facility fee |
398 |
355 |
$5K |
| 20550 |
|
41 |
34 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$4K |
| 82728 |
|
769 |
758 |
$4K |
| 77080 |
|
79 |
79 |
$4K |
| 73562 |
|
184 |
166 |
$4K |
| 97035 |
|
712 |
312 |
$4K |
| 80143 |
|
1,149 |
1,054 |
$4K |
| 84703 |
|
10,814 |
9,855 |
$4K |
| 76813 |
|
106 |
102 |
$4K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
783 |
775 |
$4K |
| 93225 |
|
570 |
544 |
$3K |
| 86780 |
|
494 |
487 |
$3K |
| 76641 |
|
44 |
35 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,263 |
3,724 |
$3K |
| 83735 |
|
6,227 |
5,090 |
$3K |
| 10061 |
|
13 |
12 |
$3K |
| 86140 |
|
4,019 |
3,600 |
$3K |
| 70486 |
|
161 |
154 |
$3K |
| 86803 |
|
747 |
738 |
$3K |
| 0011A |
|
135 |
128 |
$3K |
| 70487 |
|
18 |
17 |
$3K |
| 82570 |
|
1,685 |
1,492 |
$3K |
| 87070 |
|
2,852 |
2,628 |
$3K |
| 95886 |
|
12 |
12 |
$3K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
13 |
13 |
$2K |
| 85610 |
|
14,168 |
9,611 |
$2K |
| 72131 |
|
395 |
370 |
$2K |
| 86592 |
|
412 |
404 |
$2K |
| 86850 |
|
1,431 |
1,350 |
$2K |
| 84702 |
|
2,281 |
1,978 |
$2K |
| 87507 |
|
42 |
37 |
$2K |
| 86900 |
|
2,722 |
2,085 |
$2K |
| 81001 |
|
9,997 |
9,277 |
$2K |
| 82077 |
|
4,738 |
3,969 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
14,900 |
12,266 |
$2K |
| 80179 |
|
1,079 |
997 |
$2K |
| 87077 |
|
2,404 |
2,275 |
$2K |
| 72110 |
|
210 |
203 |
$2K |
| 82962 |
|
9,079 |
6,216 |
$2K |
| 81003 |
|
13,197 |
11,968 |
$1K |
| 83690 |
|
12,086 |
10,752 |
$1K |
| 87186 |
|
2,645 |
2,424 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
159 |
153 |
$1K |
| 84481 |
|
329 |
320 |
$1K |
| 85652 |
|
3,166 |
2,811 |
$1K |
| 73700 |
|
24 |
24 |
$1K |
| 83550 |
|
460 |
454 |
$1K |
| 87340 |
|
520 |
510 |
$1K |
| 76857 |
|
13 |
13 |
$1K |
| 87081 |
|
305 |
299 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,522 |
1,413 |
$1K |
| 73080 |
|
154 |
140 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,126 |
4,661 |
$1K |
| 82565 |
|
1,168 |
1,041 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
316 |
303 |
$1K |
| 74018 |
|
176 |
160 |
$1K |
| 76937 |
|
19 |
17 |
$1K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
75 |
70 |
$1K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
836 |
808 |
$1K |
| 72040 |
|
130 |
124 |
$1K |
| 97760 |
|
43 |
30 |
$1K |
| 86901 |
|
1,796 |
1,553 |
$980.01 |
| 87641 |
|
101 |
97 |
$949.05 |
| 90686 |
|
92 |
88 |
$925.74 |
| 0012A |
|
31 |
31 |
$900.22 |
| 82550 |
|
1,436 |
1,247 |
$883.13 |
| 73560 |
|
71 |
63 |
$875.69 |
| 82746 |
|
265 |
264 |
$862.66 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
914 |
818 |
$857.83 |
| 83540 |
|
544 |
536 |
$855.69 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
10,192 |
8,519 |
$835.51 |
| 87205 |
|
2,154 |
1,965 |
$822.02 |
| 86762 |
|
225 |
220 |
$787.43 |
| 86038 |
|
230 |
225 |
$744.54 |
| 84550 |
|
1,099 |
945 |
$726.93 |
| 84403 |
|
148 |
144 |
$712.01 |
| 84153 |
|
105 |
104 |
$699.57 |
| 36000 |
|
2,542 |
2,442 |
$680.68 |
| 82043 |
|
636 |
625 |
$659.49 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
13 |
13 |
$650.57 |
| 72128 |
|
175 |
159 |
$648.18 |
| 85730 |
|
2,419 |
2,297 |
$617.77 |
| 72120 |
|
180 |
175 |
$613.11 |
| 84100 |
|
963 |
669 |
$588.95 |
| 97163 |
|
12 |
12 |
$561.22 |
| J1756 |
Injection, iron sucrose, 1 mg |
33 |
13 |
$546.43 |
| 82950 |
|
165 |
158 |
$521.38 |
| 96127 |
|
106 |
103 |
$514.56 |
| 82951 |
|
73 |
70 |
$513.93 |
| 86787 |
|
147 |
144 |
$508.78 |
| J7050 |
Infusion, normal saline solution, 250 cc |
13,531 |
10,835 |
$501.30 |
| 87088 |
|
740 |
715 |
$487.23 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
15,020 |
7,657 |
$477.54 |
| 93246 |
|
31 |
30 |
$466.95 |
| 82105 |
|
59 |
57 |
$463.19 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
78 |
77 |
$461.52 |
| 83970 |
|
40 |
39 |
$449.85 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,863 |
1,756 |
$430.20 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
21,367 |
16,596 |
$425.17 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
57 |
55 |
$407.73 |
| 96376 |
|
5,757 |
5,006 |
$399.35 |
| 84156 |
|
533 |
441 |
$390.75 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
887 |
850 |
$369.06 |
| 84450 |
|
469 |
392 |
$353.30 |
| 86317 |
|
73 |
72 |
$346.72 |
| 64447 |
|
12 |
12 |
$316.54 |
| 87634 |
|
333 |
295 |
$308.29 |
| 84460 |
|
571 |
482 |
$307.10 |
| 87075 |
|
1,241 |
1,121 |
$306.25 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,015 |
1,905 |
$304.16 |
| 83001 |
|
43 |
43 |
$277.12 |
| 74019 |
|
29 |
25 |
$273.17 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
26 |
26 |
$266.26 |
| 86480 |
|
13 |
13 |
$256.79 |
| 76000 |
|
14 |
13 |
$255.61 |
| 86704 |
|
84 |
83 |
$250.22 |
| 85014 |
|
464 |
412 |
$238.85 |
| 90677 |
|
12 |
12 |
$231.91 |
| 99409 |
|
13 |
12 |
$230.60 |
| 80069 |
|
70 |
63 |
$204.04 |
| 73590 |
|
54 |
51 |
$201.93 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
10,261 |
9,422 |
$187.98 |
| J1815 |
Injection, insulin, per 5 units |
786 |
490 |
$183.24 |
| 84146 |
|
31 |
30 |
$176.77 |
| A9270 |
Non-covered item or service |
5,384 |
3,333 |
$175.27 |
| 85018 |
|
564 |
515 |
$173.73 |
| 90662 |
|
136 |
134 |
$166.42 |
| 82248 |
|
604 |
571 |
$159.74 |
| 90674 |
|
17 |
15 |
$135.42 |
| 81025 |
|
687 |
647 |
$134.18 |
| 84402 |
|
24 |
24 |
$133.38 |
| 84520 |
|
251 |
208 |
$127.70 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
10,571 |
8,964 |
$126.09 |
| 84112 |
|
12 |
12 |
$124.36 |
| J2704 |
Injection, propofol, 10 mg |
9,082 |
7,189 |
$99.79 |
| 80178 |
|
12 |
12 |
$96.69 |
| 94664 |
|
143 |
136 |
$94.61 |
| 87210 |
|
197 |
187 |
$90.88 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
13 |
13 |
$84.15 |
| 72050 |
|
25 |
24 |
$81.80 |
| 86765 |
|
25 |
24 |
$77.31 |
| 83516 |
|
42 |
39 |
$76.75 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
602 |
488 |
$74.13 |
| 88304 |
|
228 |
219 |
$71.82 |
| 87430 |
|
491 |
462 |
$71.73 |
| J2060 |
Injection, lorazepam, 2 mg |
5,159 |
3,697 |
$66.29 |
| 86431 |
|
39 |
39 |
$66.07 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,480 |
1,171 |
$65.90 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
397 |
371 |
$65.66 |
| 93242 |
|
14 |
13 |
$61.41 |
| 73660 |
|
12 |
12 |
$57.72 |
| 73090 |
|
14 |
12 |
$55.79 |
| 83002 |
|
12 |
12 |
$54.04 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
11,973 |
7,798 |
$51.20 |
| 82330 |
|
186 |
169 |
$47.66 |
| 80050 |
General health panel |
29 |
28 |
$46.37 |
| 87800 |
|
13 |
12 |
$45.69 |
| 0001A |
|
18 |
15 |
$43.20 |
| 86200 |
|
13 |
13 |
$41.50 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,780 |
1,513 |
$40.23 |
| 82784 |
|
33 |
31 |
$38.89 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,247 |
1,665 |
$35.84 |
| 81002 |
|
2,400 |
2,217 |
$29.07 |
| 97597 |
|
42 |
26 |
$25.89 |
| 99152 |
|
450 |
408 |
$25.07 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
6,695 |
4,829 |
$23.28 |
| 82009 |
|
117 |
102 |
$22.60 |
| 0352U |
|
318 |
315 |
$22.49 |
| C9113 |
Injection, pantoprazole sodium, per vial |
346 |
279 |
$22.27 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,489 |
3,247 |
$20.96 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
194 |
160 |
$19.60 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
154 |
146 |
$18.66 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
1,692 |
1,551 |
$17.58 |
| 99153 |
Mod sedat endo service >5yrs |
62 |
53 |
$17.54 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
225 |
211 |
$13.26 |
| 84425 |
|
15 |
14 |
$12.75 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
746 |
598 |
$12.71 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
230 |
206 |
$9.15 |
| 99406 |
|
31 |
24 |
$8.56 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,840 |
2,564 |
$7.16 |
| C1769 |
Guide wire |
1,437 |
1,347 |
$3.84 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
4,401 |
3,887 |
$3.69 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
567 |
475 |
$2.94 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,894 |
1,686 |
$2.43 |
| J1630 |
Injection, haloperidol, up to 5 mg |
273 |
213 |
$1.85 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
644 |
601 |
$0.78 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,051 |
970 |
$0.33 |
| J1644 |
Injection, heparin sodium, per 1000 units |
877 |
506 |
$0.16 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
278 |
251 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
244 |
228 |
$0.00 |
| 76376 |
|
39 |
37 |
$0.00 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
303 |
283 |
$0.00 |
| C1776 |
Joint device (implantable) |
15 |
15 |
$0.00 |
| J0153 |
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) |
113 |
106 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
414 |
340 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
70 |
58 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
129 |
104 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
45 |
40 |
$0.00 |
| G0390 |
Trauma response team associated with hospital critical care service |
12 |
12 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
16 |
12 |
$0.00 |
| 90653 |
|
55 |
53 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
49 |
46 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
82 |
27 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
388 |
321 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
160 |
140 |
$0.00 |
| 87154 |
|
215 |
205 |
$0.00 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
296 |
280 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
79 |
78 |
$0.00 |
| 0240U |
|
120 |
114 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
105 |
105 |
$0.00 |
| 82803 |
|
70 |
63 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
194 |
183 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
30 |
25 |
$0.00 |
| 82150 |
|
17 |
17 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
13 |
12 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
15 |
15 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
16 |
14 |
$0.00 |
| 93280 |
|
12 |
12 |
$0.00 |